The octapeptide angiotensin II (Asp 1 8 , AII) interacts mainly with two specific receptor proteins, AT-1 and AT-2 (1). Out of these two, AT-1 is the primary vascular receptor associated with blood pressure regulation. It mediates virtually all of the known physiological actions of AII in cardiovascular, renal, neuronal, endocrine, hepatic, and other target cells (1) . AT-1 receptors are highly homologous between various species (up to 95% (2)). AT-1 also has high homology with rhodopsin (Rh) and with the other members of the rhodopsin family of the G-protein-coupled receptors (GPCRs); see, e.g., (3) . Therefore, the study of molecular mechanisms involved in AII-AT-1 interaction benefits rational design of new ligands of AT-1 and new mutants of that receptor, and also serves as a valuable prototype for the entire rhodopsin family of GPCRs.
Molecular determinants of the AII-AT-1 interaction are present both in the peptide ligand as well as the transmembrane receptor. On the ligand side, many very extensive structure-activity studies with AII analogs (e.g., (4, 5) and references therein) showed that the moieties indispensable both for binding to the AT-1 receptor and for initiating signal transduction are the side chains of Tyr 4 , His 6 , Phe 8 , and the C-terminal carboxyl. Phe 8 is especially important for agonistic activity: a single replacement of Phe 8 for an aliphatic residue, as Ile 8 , results in an AII antagonist (4) . The three-dimensional (3D) structure of the octapeptide AII has been repeatedly studied by many physicochemical methods including NMR, CD, IR, etc. (though not X-ray crystallography; the only exception was the complex of AII with an antibody (6) ). Several 3D models of the "receptor-bound" conformation of AII have been suggested by molecular modeling and NMR spectroscopy of rigidified analogs of AII. We have developed one of these models previously (7, 8) ; this model became widely accepted in AII and AT-1 studies by other authors (3, 9, 10) .
On the receptor side, during the last several years, a variety of mutants of AT-1 have been expressed and tested for ligand binding and for inositol phosphate (IP) production (for reviews see, e.g., (9, 11) ). More than 40 residues in AT-1 have been shown to be sensitive either to ligand binding or to signal transduction (see Table 1 ). In structural terms, AT-1 belongs to the so-called 7-transmembrane (7TM) proteins whose transmembrane part consists mainly of the 7-helical bundle. Very few experimental data are available on the 3D structure of AT-1. They include studies on the isolated AT-1 fragments (e.g., (12) ), and some recent experimental studies employing the AII analogs with individual amino acid substitutions for Bpa (p-benzoyl-L-phenylalanyne, a photoreactive label) (13) (14) (15) . The latter studies indicate that Bpa 1 on AII may bind the AT-1 receptor at the 166 -199 region, Bpa 8 at the 285-295 region (14) , and Bpa 3 may contact position 172 (13) .
The data of site-directed mutagenesis have been used as basis for several 3D models of the AT-1 receptor and its complexes with the ligands developed by molecular modeling. The early models have been constructed based on 3D structure of bacteriorhodopsin (BR); it is commonly accepted now that BR is not a good "template" for GPCRs, since it has low-to-no homology to this family (16) and the relative orientation of transmembrane segments is different. The more recent models are based on the 3D structure of Rh that was revealed by electronic microscopy (17) or, in much more detail, by recent X-ray crystallography (18) . In all cases, however, the models have been built by placing an appropriate 3D structure of a ligand (mainly AII) in direct contact with residues of AT-1 occupying positions known to be most sensitive either to ligand binding, or to signal transduction. In this way, the data of site-directed mutagenesis for the AT-1 receptor could not be used for independent validation of the models in question, since this information was already incorporated in the models. Therefore, this study presents a 3D model of the complex between AII and the TM region of AT-1 built by molecular modeling employing only considerations of energy calculations and steric complementarity. Though not including the loop regions at this stage, such a model allows independent validation by comparison with the available data of site-directed mutagenesis.
METHODS
TM helical bundle of AT-1. Transmembrane helical fragments have been located in the sequence of the rat AT-1 receptor by sequence homology to the Rh helices found by the CLUSTAL W procedure (the URL address http://ca.expasy.org/tools). The endpoints of helices were refined by the nonstatistical procedure developed by us earlier (19) . The helical fragments have been assembled in a TM helical bundle following the procedure of "enhanced homology modeling," which consists of (i) determining conformations of individual helices by independent energy minimization involving all dihedral angles; (ii) superimposing the obtained conformations over the X-ray structure of Rh (18) according to sequence homology and, (iii) packing helices by finding the energetically best arrangement of the individual helices, in which dihedral angles of the backbone are "frozen" in the values obtained earlier. Accordingly, the variables for the packing procedure are the dihedral angles of the side chains for all helices, which are optimized by the algorithm developed earlier (20) as well as the 6 ϫ 7 ϭ 42 additional "global" parameters corresponding to movements of each helix as a rigid body. The packing procedure is described in detail elsewhere (21) . The "global" starting point for assembling the TM bundle for AT-1 has been that of the X-ray structure of Rh (18) . Energy calculations used the ECEPP force field (22, 23) ; the electrostatic term was omitted to avoid artifacts in helix packing due to its interfacial location and the complexity of the local dielectric.
Complex of AII and the TM region of AT-1. The "receptor-bound" conformation of AII deduced by us earlier (structure II from Table 2 in (7)) has been docked to the developed 3D model of TM helical bundle of AT-1 by the GRAMM molecular-docking procedure available at the URL address http://reco3.musc.edu. The suggested 3D model of AII specifies the "receptor-bound" conformation of the Val 3 -Tyr 4 -Ile/Val 5 -His 6 -Pro 7 -Phe 8 -COOH fragment of AII; we have assumed that the N-terminal fragment of AII, NH 2 -Asp 1 -Arg 2 , adopts an energetically favorable extended conformation. First, 1000 lowscoring configurations of AII within the TM helical bundle of AT-1 have been found using a low-resolution "gray" option of the GRAMM procedure (the option developed in our lab earlier (24) ; the employed GRAMM parameters were as follows: mmode ϭ generic; eta ϭ 3.8; ro ϭ 6.5; fr ϭ 0.0; crang ϭ grid_step; ccti ϭ grey; crep ϭ all; maxm ϭ 1000, and ai ϭ 20). These configurations were considered further as possible starting points for energy minimization of the entire complex. The configurations without a significant number of possible sterical clashes were selected as the actual starting points for energy minimization performed by the same computational procedure used previously for helix packing. In this case, however, the procedure involved independent movements in the space of 6 ϫ 8 ϭ 48 "global" parameters (seven helices plus AII) as well as optimization of the dihedral angles of the side chains for all helices and AII by the algorithm developed earlier (20) .
RESULTS AND DISCUSSION

3D Models for the Complex of AII and TM region of AT-1
Our procedure for helix packing has been validated earlier by packing TM helices of BR (21) . Starting from the "global" parameters corresponding to the X-ray structure of BR (25) , energy minimization reproduced a TM bundle that differed from the X-ray structure by the rmsd value of only 1.14 Å (the rmsd values calculated for C␣ atoms are mentioned here and further throughout the text). For AT-1, helical fragments have been identified as described above (see the underlined segments in Table 1 ). They have been packed in a bundle that differed from the initial X-ray structure of Rh by the rmsd value of 2.5 Å.
The GRAMM procedure obtained 1000 low-scoring configurations for the complex of AII and AT-1. The 100 configurations with the most favorable values of the GRAMM scoring function all concentrated in the spatial position at the extracellular "entry" into the TM helical bundle differing mainly by their general orientation of the N-terminal end of AII "outside" or "inside" the bundle. Out of top 50, only 19 configurations possessed less than 10 close contacts (Ͻ3 Å) between the backbone atoms of AT-1 and AII. Those 19 configurations have been selected as the starting points for energy minimization. Since our energy estimations were performed for a large complex (about 160 residues altogether), and did not account for possible influence of interactions with the outside loops as well as for electrostatic interactions, we have assumed a generous threshold of 50 kcal/mol in relative conformational energy for selection of the potentially low-energy complexes of AII with AT-1. Our calculations found 11 of them, which converged into four geometrically similar "families" according to the "global" spatial positions of AII. Table 1 summarizes the current data on the AT-1 mutants (mostly for the rat AT-1 receptor) that have been tested for binding of extracellular peptide ligands (mostly AII) (26 -33) , intracellular ligand binding (binding to a heterotrimeric G-protein (34)) (35) (36) (37) (38) (39) , and for IP production (10, 31-33, 40 -49) . Generally, it was shown that the positions most sensitive to extracellular ligand binding are those occupied in the wildtype (WT) receptor by I14, H24, Y26, I27, T88, M90, Y92, K102, H166, R167, V179, H183, Y184, E185, K199, F259, T260, D262, H272, D278, D281, and N295 (shown in bold italics in Table 1 ). The positions mostly BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS sensitive to IP production are those occupied in WT by F77, L78, S107, F110, N111, S115, L118, M142, L143, P162, E173, A181, I193, L195, T198, I245, W253, V254, H256, Y292, N294, and L305 (shown in bold in Table 1 ). Several residues have been shown as the most important for constitutive activity, namely F77, N111, L112, L118, L195, and I245 (also shown in bold in Table 1 ). Totally, 23 residues were shown to be involved in signal transduction or in manifestation of constitutive activity, 19 of them being located in the TM region of the AT-1 receptor. 22 residues were shown to be involved in external ligand binding; only seven of them are located in the TM region of the AT-1 receptor.
Validation/Selection of the Most Plausible 3D Model of the Complex
With some caveats (for instance, different positions in AT-1 may be important for binding of different extracellular ligands (26, 28) ), the data of site-directed mutagenesis collected in Table 1 may be used for selection and independent validation of the most plausible 3D model for the AII-AT1 complex. Table 2 lists the interatomic contacts (Ͻ4.0 Å) between all residues of AII and AT-1 in all four possible families of the AII-AT-1 complexes obtained by our calculations (the order of families is arbitrary). For each family, the AT-1 residues involved in signal transduction or in constitutive activity according to the data of site-directed mutagenesis are shown in bold, and residues possibly involved in ligand binding are shown in bold italics, respectively. Shaded areas in Table 2 correspond to AII moieties that are most important for displaying agonistic activity of AII analogs, namely to Tyr 4 , His 6 , Phe 8 , and the C-terminal carboxyl. In a quite reasonable assumption that the residues of AII, that are most important for agonist activity, are more likely to contact the AT-1 residues involved into either signal transduction or constitutive activity, the most plausible model for the AII-AT-1 complex is that corresponding to family 2. Interestingly, this particular model also possesses the lowest energy according to our calculations (Ϫ476.3 kcal/mol in the selected force field). In terms of conformational energy, AII interacts primarily with TM helices III and VI (energies of interaction are Ϫ26.3 and Ϫ23.9 kcal/mol, respectively), then with helices V and VII (Ϫ15.3 and Ϫ14.4 kcal/mol), and then with the helix II (Ϫ5.0 kcal/mol); interactions with helices I and IV are practically absent. Figure 1 shows that the selected model provides a well-packed structure with significant penetration of the crucial Phe 8 residue of AII inside the helical bundle. The nearest environment of the functionally important Tyr 4 , His 6 , and Phe 8 residues includes seven residues of AT-1, which are known to be involved in signal transduction or constitutive activity, namely F77, N111, L112, W253, H256, Y292, and H294. The Tyr 4 residue presumably interacts also with the corresponding residues in the extracellular loops. Figure 2 depicts the view from the intracellular side to the selected 3D model of the AII-AT-1 complex in comparison with the model of the TM helical bundle of AT-1 optimized without AII (two helices noninteracting with AII, I and IV, are overlapped in Fig. 2 ). Generally, "global" movements of helices as rigid bodies to accommodate the ligand are small, the corresponding overall rmsd value being 1.83 Å. This is in line with the experimentally observed small movements of TM helices in BR upon transitions from the "dark" to the "light" states (50 -52) . However, as is evident from Fig.  2 , the movements of the ends of the individual helices within the bundle may be rather significant, especially for the intracellular end of helix V. This observation is in good agreement with the experimental data suggesting that many AT-1 residues most sensitive to interaction with the intracellular ligand, a G-protein, are located in the intracellular loop between helices V and VI ((38); see also Table 1 ). Also, according to our model, several residues of AT-1 experience significant conformational transitions in their side chains (⌬ 1 values greater than 60°) upon binding of AII to AT-1. Those in direct contact with AII, namely L112, F204, F249, and W253, are depicted in Fig. 2 .
Comparison with 3D Models Suggested by Other Authors
As it was mentioned above, the early models of the AII-AT-1 complex have been based on 3D structure of BR. The model proposed by the Scheraga and Maigret modeling groups (42, 53) describes the AII-AT-1 complex, where AII adopts the "receptor-bound" conformation predicted by the same groups earlier (54) , and this conformation is docked to AT-1 by electrostatic interactions between the ␣-and/or ␤-carboxyls of Asp 1 in AII and the side chain of K199 in AT-1 (53) . The difference between the "empty" and "occupied" states of AT-1 in this model has been interpreted as the difference between two conformational states where the hydroxyl of the Y292 side chain forms a hydrogen bond either with the ␤-carbonyl of N111, or with the ␤-carboxyl of D74 (42) . The model by the Inagami group (9, 29) was similar to the previous one, except it used the "receptor-bound" conformation of AII developed by us previously (7, 8) . The Inagami model suggested that the Y292 side chain in the "empty" state maintains hydrogen bonding with the N295 side chain, and, upon AII binding, switches to hydrogen bonding with D74, as in the Scheraga/Maigret model. This switching involves concerted rotations of two TM helices, namely helices II and VII (9) . The other model, based both on BR and on the rough structure of Rh determined by electron microscopy (17) , also has placed K199 in direct interaction with the ␣-carboxyl of Phe 8 . The model suggests interactions between D281 and Arg 2 in AII (32), between H256 and the side chain of Phe 8 (32) , and between N111 and Tyr/Phe 4 (10) . This model also utilizes our model of the "receptor-bound" conformation of AII, as well as the model proposed by the Paiva/Oliveira group (3), which was also based on the rough structure of Rh. In this model, AII interacts with K199 and D281 in the same way as described above; Tyr 4 is inserted into the transmembrane pocket, but not interacts with N111 directly. The authors have developed this model further taking into account the G-protein activation (55) , and the much more detailed X-ray structure of Rh (see the URL address http:// www.gpcr.org/7tm/models/oliveira/index.html). The most recent 3D model of AT-1 is also based on the Rh structure and on the binding data for the Bpa-containing analogs of AII (13) . In this model, the fully extended structure of AII is deeply immersed in the TM region, with Val 3 interacting with I172, and Phe 8 interacting with F293 and N294.
One main difference between our model and all of the previous models (except the last one (13) ) is that our model places Phe 8 , but not Tyr 4 , in direct vicinity of the extremely important residues N111, H256, Y292, N294, and N295 deeply buried inside the TM helical bundle of AT-1. This seems more consistent with the experimental results showing that the photolabeled analog [Bpa 8 ]-AII binds AT-1 in the 285-295 region (14) . The deep immersion into the TM bundle of Phe 8 , and not Tyr 4 also agrees with the very recent experimental observation that among many dimers of AII obtained by bridging various side chains via aliphatic -amino carboxylic acid linkers, only those linked through position 4 displayed sub-micromolar affinities when binding to AT-1 receptors (15) . Another significant difference is that conformational transition from the "empty" to "occupied" states of AT-1 in our model is not limited to any specific inter-residue interaction, as Y292-D74. Instead, our model views the process of signal transduction through the TM region of AT-1 as a chain of cooperative conformational perturbations of many side chains, which is initiated by those residues directly affected by binding of AII. According to this paradigm, sensitivity of a given receptor residue to ligand binding, or to signal transduction does not mean that this residue should necessarily be in direct contact with the bound ligand; there may be many pathways to involve these residues in conformational transitions. The on-going site-directed mutagenesis studies would certainly identify new residues involved in signal transduction in AT-1; this is one more reason not to be confined by a model considering only one possible pathway for this process. In fact, we have recently suggested several new "signal transduction" residues in the TM region of AT-1 based on conformational studies of the AT-1 mutants showing constitutive activity, namely residues Y35, L119, F249, S252, I288, N295, and N298 (56) .
CONCLUSION
This study is the first one presenting 3D models of the AII-AT-1 complex obtained by steric and energy considerations only, without prior knowledge of the experimental results of site-directed mutagenesis for the AT-1 receptor mutants. Therefore, the available data of site-directed mutagenesis could be used for independent validation of the suggested models, which singled out one of the models as the most plausible. No other model of the AII-AT-1 complex described in the literature allows such validation, since all of them use the data on the AT-1 mutants beforehand. Also, no other approach offers several 3D models of the AII-AT-1 complex for further evaluation. Our final 3D model of the complex of AII and the TM helical bundle of AT-1 brings in contact the residues of AII responsible for agonistic activity, Tyr 4 , His 6 , and Phe 8 , and many residues of AT-1 involved in signal transduction according to the data of site-directed mutagenesis. The model predicts the existence of several possible conformational pathways for transferring signal through the TM region of AT-1.
